We serve as lead outside counsel for a global Fortune 500 media company negotiating data protection and privacy agreements and contractual terms, including for engagements of ad tech, security infrastructure, financial services, and clinical healthcare service providers, as well as advising on U.S. and international security and privacy regulations and self-regulatory framework compliance.
Negotiations of Data Protection and Privacy Agreements for Fortune 500 Media Company
You Also May Be Interested In:
Lead Counsel to POINT Biopharma Inc. in its Proposed SPAC Business Combination with Research Alliance Corp. I
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.
Represented Boston Children’s Hospital with intellectual property, business, and government contracting issues associated with VaccineFinder
We represented Tractor Supply Company (Nasdaq: TSCO) in their agreement to acquire Orscheln Farm and Home, a family-owned farm and ranch retailer.